Potential Mechanisms of Action for Vitamin C in Cancer: Reviewing the Evidence
/in International Publications, MicronutrientsRecurrent Glioblastoma Treated with Recombinant Poliovirus
/in Glioblastoma, International Publications, Newcastle Disease VirusLysis-independent potentiation of immune checkpoint blockade by oncolytic virus
/in Checkpoint-Inhibitors, International Publications, Newcastle Disease VirusChemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
/in Breast Cancer, Hyperthermia, International PublicationsTargeting dendritic cells in pancreatic ductal adenocarcinoma
/in Dendritic Cells, Exosome, International Publications, Pancreatic CancerHyperthermia in cervical cancer – current status
/in Cervical Cancer, Hyperthermia, International PublicationsInterim analysis of a prospective, randomized, double blind, placebo controlled, phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected stage III or IV melanoma patients.
/in Dendritic Cells, International Publications, Malignant MelanomaNew physical approaches to treat cancer stem cells: a review
/in Hyperthermia, International Publications
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer